Inferior infarction following alcohol septal ablation: A consequence of "collateral damage"?

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 2, 2007, Pages 236-242

  Chowdhary, Saqib ^a   Galiwango, Paul ^b   Woo, Anna ^b   Schwartz, Leonard ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Coronary collaterals; Hypertrophic obstructive cardiomyopathy; Left ventricular; Outflow tract gradient

Indexed keywords

ALCOHOL; ATENOLOL; DISOPYRAMIDE; PERFLUTREN; SHU 508;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DRUG TREATMENT FAILURE; DYSPNEA; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE ENHANCEMENT; MALE; MITRAL VALVE REGURGITATION; SYMPTOM; TRANSCATHETER ALCOHOL SEPTAL ABLATION;

AGED; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMBOLIZATION, THERAPEUTIC; ETHANOL; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 33846785345     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20941     Document Type: Article

References (12)

1. van der Lee C, ten Cate FJ, Geleijnse ML, Kofflard MJ, Pedone C, van Herwerden LA, Biagini E, Vletter WB, Serruys PW. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation 2005;112:482-488.
2. Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle ED, Williams WG. Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 2005;129:351-358.
3. Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
4. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik AJ, Spencer WH. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-1706.
5. Singh M, Edwards WD, Holmes DR Jr, Tajil AJ, Nishimura RA. Anatomy of the first septal perforating artery: A study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc 2001;76:799-802.
6. Faber L, Seggewiss H, Ziemssen P, Gleichmann U. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area. Catheter Cardiovasc Interv 1999;47:462-466.
7. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713.
8. Elliott PM, Brecker SJ, McKenna WJ. Left ventricular opacification during selective intracoronary injection of echocardiographic contrast in patients with hypertrophic cardiomyopathy. Heart 2000;83:E7.
9. Sigwart U., Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
10. Agarwal SC, Purcell IF, Furniss SS. Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation. Heart 2005;91:e2.
11. Parham WA, Kem MJ. Apical infarct via septal collateralization complicating transluminal alcohol septal ablation for hypertrophic cardiomyopathy. Catheter Cardiovasc Interv 2003;60:208-211.
12. Wustmann K, Zbinden S, Windecker S, Meier B, Seiler C. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation 2003;107:2213-2220.